AU2002252532A1 - Methods for using kdop and kdop synthase inhibitors for the treatment of bacterial infection - Google Patents

Methods for using kdop and kdop synthase inhibitors for the treatment of bacterial infection

Info

Publication number
AU2002252532A1
AU2002252532A1 AU2002252532A AU2002252532A AU2002252532A1 AU 2002252532 A1 AU2002252532 A1 AU 2002252532A1 AU 2002252532 A AU2002252532 A AU 2002252532A AU 2002252532 A AU2002252532 A AU 2002252532A AU 2002252532 A1 AU2002252532 A1 AU 2002252532A1
Authority
AU
Australia
Prior art keywords
kdop
treatment
methods
bacterial infection
synthase inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002252532A
Inventor
Jonathan M. Friedman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fazix Corp
Original Assignee
Fazix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fazix Corp filed Critical Fazix Corp
Publication of AU2002252532A1 publication Critical patent/AU2002252532A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002252532A 2001-03-30 2002-03-29 Methods for using kdop and kdop synthase inhibitors for the treatment of bacterial infection Abandoned AU2002252532A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27998801P 2001-03-30 2001-03-30
US60/279,988 2001-03-30
PCT/US2002/009612 WO2002078634A2 (en) 2001-03-30 2002-03-29 Methods for using kdop and kdop synthase inhibitors for the treatment of bacterial infection

Publications (1)

Publication Number Publication Date
AU2002252532A1 true AU2002252532A1 (en) 2002-10-15

Family

ID=23071173

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002252532A Abandoned AU2002252532A1 (en) 2001-03-30 2002-03-29 Methods for using kdop and kdop synthase inhibitors for the treatment of bacterial infection

Country Status (2)

Country Link
AU (1) AU2002252532A1 (en)
WO (1) WO2002078634A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613590A (en) * 1985-08-19 1986-09-23 Abbott Laboratories Amino D-manno-2-octulopyranosidonate containing compounds, pharmaceutical compositions and method of use
SE8506095D0 (en) * 1985-12-20 1985-12-20 Astra Laekemedel Ab NEW ENZYME INHIBITOR

Also Published As

Publication number Publication date
WO2002078634A2 (en) 2002-10-10
WO2002078634A3 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
AU2002257936A1 (en) Methods of well treatment
AU2002326600A1 (en) Side-exit catheter and method for its use
AU2003300200A1 (en) Valve treatment catheter and methods
AU2002332438A1 (en) Media and methods for cultivation of microorganisms
AU2002215261A1 (en) Method and arrangement for treatment of fluid
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
AU2002356868A1 (en) Methods for the prevention or treatment of bacterial and fungal infections
AU2002248269A1 (en) Use of p38 inhibitors for the treatment of inflammation-enhanced cough
AU2001286983A1 (en) Method of treatment
AU2003225946A1 (en) Methods and compositions for vaccination against or involvingenterobacteriaceae bacteria
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
AU2003260778A1 (en) Treatment of pipes
AU2002361548A1 (en) Compositions and methods for bacteria detection
AU2003259202A1 (en) Compositions and methods for treating and preventing infection
AU2003249930A1 (en) Proteaseome inhibitors for the treatment of herpesviridae infected individuals
AU2002326303A1 (en) Methods for attenuation of virulence in bacteria
AU2002334761A1 (en) Methods of treating drug-resistant bacterial infections
AU2001262177A1 (en) Method of treatment
AUPR731901A0 (en) Method of treatment
AU2002252532A1 (en) Methods for using kdop and kdop synthase inhibitors for the treatment of bacterial infection
AU2003290506A1 (en) Methods and devices for treating severe peripheral bacterial infections
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
AU2002342715A1 (en) Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
AU2003304316A1 (en) Compounds and methods for the treatment and prevention of bacterial infection
AU2001253560A1 (en) Methods of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase